Taiwan's non-profit Development Center for Biotechnology (DCB) announced Monday that it has synthesized favilavir, an experimental medication being used in other countries as an investigational therapy to combat the COVID-19 coronavirus.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Government platform touts 60-80% reduction in statutory animal testing
04/25/2024 10:58 PM - Society
Traffic controls to be enforced at Taipei rallies Saturday
04/25/2024 10:43 PM - Society
High school student injured in earthquake dies
04/25/2024 10:31 PM - Society
Taiwan to remove points system for foreign, overseas compatriot students
04/25/2024 10:06 PM - Culture
Polaroid exhibition showcases work by influential artists, iconic cameras
04/25/2024 09:56 PM